How to buy Theratechnologies (THTX) stock

Theratechnologies Inc is a drug manufacturers-specialty & generic business based in the US. Theratechnologies shares (THTX) are listed on the NASDAQ and all prices are listed in US Dollars. Theratechnologies employs 54 staff and has a trailing 12-month revenue of around 0.00.

Theratechnologies stock price (NASDAQ: THTX)

Use our graph to track the performance of THTX stocks over time.

Theratechnologies shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$3.54
52-week range	$1.83 - $4.25
50-day moving average	$3.68
200-day moving average	$3.32
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.29

Buy Theratechnologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Theratechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Theratechnologies Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Theratechnologies price performance over time

Historical closes compared with the close of $3.54 from 2021-06-08

1 week (2021-07-14)	N/A
1 month (2021-06-25)	-9.00%
3 months (2021-04-21)	N/A
6 months (2021-01-21)	N/A

1 year (2020-07-21)	N/A
2 years (2019-07-21)	N/A
3 years (2018-07-21)	N/A
5 years (2016-07-21)	N/A

Is Theratechnologies under- or over-valued?

Valuing Theratechnologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Theratechnologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Theratechnologies's EBITDA

Theratechnologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 million.

The EBITDA is a measure of a Theratechnologies's overall financial performance and is widely used to measure a its profitability.

Theratechnologies financials

Revenue TTM	$66.4 million
Gross profit TTM	$44 million
Return on assets TTM	-10.2%
Return on equity TTM	-97.39%
Profit margin	-37.1%
Book value	$0.37
Market capitalisation	$339.9 million

TTM: trailing 12 months

Shorting Theratechnologies shares

There are currently 183,078 Theratechnologies shares held short by investors – that's known as Theratechnologies's "short interest". This figure is 14.8% down from 214,896 last month.

There are a few different ways that this level of interest in shorting Theratechnologies shares can be evaluated.

Theratechnologies's "short interest ratio" (SIR)

Theratechnologies's "short interest ratio" (SIR) is the quantity of Theratechnologies shares currently shorted divided by the average quantity of Theratechnologies shares traded daily (recently around 88443.47826087). Theratechnologies's SIR currently stands at 2.07. In other words for every 100,000 Theratechnologies shares traded daily on the market, roughly 2070 shares are currently held short.

However Theratechnologies's short interest can also be evaluated against the total number of Theratechnologies shares, or, against the total number of tradable Theratechnologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Theratechnologies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Theratechnologies shares in existence, roughly 0 shares are currently held short) or 0.0021% of the tradable shares (for every 100,000 tradable Theratechnologies shares, roughly 2 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Theratechnologies.

Find out more about how you can short Theratechnologies stock.

Theratechnologies share dividends

We're not expecting Theratechnologies to pay a dividend over the next 12 months.

Theratechnologies share price volatility

Over the last 12 months, Theratechnologies's shares have ranged in value from as little as $1.83 up to $4.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Theratechnologies's is 1.7475. This would suggest that Theratechnologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Theratechnologies overview

Theratechnologies Inc. , a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada. .

Frequently asked questions

What percentage of Theratechnologies is owned by insiders or institutions?
Currently 1.181% of Theratechnologies shares are held by insiders and 24.649% by institutions. How many people work for Theratechnologies?
Latest data suggests 54 work at Theratechnologies. When does the fiscal year end for Theratechnologies?
Theratechnologies's fiscal year ends in November. Where is Theratechnologies based?
Theratechnologies's address is: 2015 Peel Street, Montreal, QC, Canada, H3A 1T8 What is Theratechnologies's ISIN number?
Theratechnologies's international securities identification number is: CA88338H1001 What is Theratechnologies's CUSIP number?
Theratechnologies's Committee on Uniform Securities Identification Procedures number is: 88338H100